Biothera Names Dr. Jeremy Graff SVP Of Pharmaceutical Research

EAGAN, Minn.--(BUSINESS WIRE)--Biothera announced today the appointment of Jeremy R. Graff, Ph.D., as Senior Vice President, Research, for its Pharmaceutical Group. Most recently, Dr. Graff served as a Research Fellow and Group Leader, Oncology Patient Tailoring at Eli Lilly and Company. Dr. Graff has extensive experience across the spectrum of drug discovery and development, having led numerous programs from target inception and screen enablement through early and late stage clinical development. His lab was the first to bring forward a therapy targeting the mRNA translational regulator, eIF4E. He also led the efforts to establish the therapeutic mechanism of action for numerous early phase clinical assets --most notably the small molecule kinase inhibitor, enzastaurin, in Diffuse Large B Cell Lymphoma and glioblastoma. Most recently, he shared responsibility for developing and leading the Translational Oncology efforts within Lilly Oncology.

Help employers find you! Check out all the jobs and post your resume.

Back to news